ID: ALA4759464

Max Phase: Preclinical

Molecular Formula: C19H16N2O2S

Molecular Weight: 336.42

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1cccc(N2C(=O)CSC2c2ccc3cccc(O)c3n2)c1

Standard InChI:  InChI=1S/C19H16N2O2S/c1-12-4-2-6-14(10-12)21-17(23)11-24-19(21)15-9-8-13-5-3-7-16(22)18(13)20-15/h2-10,19,22H,11H2,1H3

Standard InChI Key:  DMQGRBRYANBFPS-UHFFFAOYSA-N

Associated Targets(Human)

Methionine aminopeptidase 1 614 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 336.42Molecular Weight (Monoisotopic): 336.0932AlogP: 4.03#Rotatable Bonds: 2
Polar Surface Area: 53.43Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.30CX Basic pKa: 3.46CX LogP: 3.78CX LogD: 3.78
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.77Np Likeness Score: -0.94

References

1. Bhat SY,Jagruthi P,Srinivas A,Arifuddin M,Qureshi IA.  (2020)  Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1.,  186  [PMID:31759728] [10.1016/j.ejmech.2019.111860]

Source